Wednesday, July 17, 2024 episode artwork

EPISODE · Jul 17, 2024 · 7 MIN

Wednesday, July 17, 2024

from The Gist Healthcare Podcast

The House Appropriations Committee is requesting that the FDA holds off on regulating laboratory developed tests. A recent report finds that private equity-backed providers account for less than 4 percent of the U.S. provider market by revenue. And a new study links semaglutide to lower risk for both dementia and nicotine use. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

The House Appropriations Committee is requesting that the FDA holds off on regulating laboratory developed tests. A recent report finds that private equity-backed providers account for less than 4 percent of the U.S. provider market by revenue. And a new study links semaglutide to lower risk for both dementia and nicotine use. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

NOW PLAYING

Wednesday, July 17, 2024

0:00 7:26

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of The Gist Healthcare Podcast?

This episode is 7 minutes long.

When was this The Gist Healthcare Podcast episode published?

This episode was published on July 17, 2024.

What is this episode about?

The House Appropriations Committee is requesting that the FDA holds off on regulating laboratory developed tests. A recent report finds that private equity-backed providers account for less than 4 percent of the U.S. provider market by revenue. And...

Can I download this The Gist Healthcare Podcast episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!